Comparative activity of the quinolones against anaerobic bacteria isolated at community hospitals.
about
In vitro activity of levofloxacin against a selected group of anaerobic bacteria isolated from skin and soft tissue infections.In vitro activities of trovafloxacin against 557 strains of anaerobic bacteria.Interactions of ciprofloxacin with clindamycin, metronidazole, cefoxitin, cefotaxime, and mezlocillin against gram-positive and gram-negative anaerobic bacteria.Susceptibilities of 428 gram-positive and -negative anaerobic bacteria to Bay y3118 compared with their susceptibilities to ciprofloxacin, clindamycin, metronidazole, piperacillin, piperacillin-tazobactam, and cefoxitin.Comparative activities of eight quinolones against members of the Bacteroides fragilis group.Comparative activity of ciprofloxacin, ofloxacin, sparfloxacin, temafloxacin, CI-960, CI-990, and WIN 57273 against anaerobic bacteriaIn vitro activities of three of the newer quinolones against anaerobic bacteria.In vitro activity of Bay Y3118 against anaerobic bacteriaEpidemiology, pathogenesis and treatment of pelvic inflammatory disease.Diagnosis and treatment of pelvic inflammatory disease.Mode of action, and in vitro and in vivo activities of the fluoroquinolones.Fluorinated quinolones. A review of their mode of action, antimicrobial activity, pharmacokinetics and clinical efficacy.The quinolones and dermatologic practice.Comparative in vitro activity of seven quinolones against 100 clinical isolates of Clostridium difficile.Therapeutic evaluation of difloxacin (A-56619) and A-56620 for experimentally induced Bacteroides fragilis-associated intra-abdominal abscess.In vitro activity of BAY y 3118, and nine other antimicrobial agents against anaerobic bacteria.Macrolides: problems and promises.
P2860
Q33693101-FE864709-523A-4BEE-A35B-8222C4FA1FCAQ35127493-4987CB06-E22B-4C17-9462-7189E44DA34AQ35541583-28BFF0F5-0679-4032-A1A2-29E0FE8F7A8DQ35817846-3B6CC4C2-0500-468A-B91D-6D2C45F5F208Q35821986-B27C642E-2AEF-4854-B145-F3D8A66BD081Q35836848-40FD88F3-C828-42CC-830A-5109A1F0B7ECQ35844319-7775DB57-41B3-4CCC-A931-750EDFEC164CQ35900446-AD47F118-9BC0-4B2F-A5AD-4EA88477D3C2Q36441494-95964064-309C-4CF6-8011-6523EC9FA026Q37346157-A6A16F60-0CAB-4503-BD73-4B1BC3F77881Q39637667-4393A1FF-05EB-4459-9CBB-BD4915E160C6Q39730719-B3B5B530-C5E8-43E2-A262-E86E396F43B7Q39743658-26BAD1C7-3D00-4FBB-BF8D-42367005590FQ39834540-AD789899-9AE5-4975-BE8C-C8939DB8CF98Q39834812-D0767976-2AD5-4CAB-A1EA-888D9641D056Q54172025-2C5D6B13-417F-42F9-B615-057B5D43CA9AQ54388935-914FF668-E142-4AAB-A19D-BFB5E78BC58A
P2860
Comparative activity of the quinolones against anaerobic bacteria isolated at community hospitals.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh
1985年學術文章
@zh-hant
name
Comparative activity of the qu ...... olated at community hospitals.
@en
Comparative activity of the qu ...... olated at community hospitals.
@nl
type
label
Comparative activity of the qu ...... olated at community hospitals.
@en
Comparative activity of the qu ...... olated at community hospitals.
@nl
prefLabel
Comparative activity of the qu ...... olated at community hospitals.
@en
Comparative activity of the qu ...... olated at community hospitals.
@nl
P2860
P356
P1476
Comparative activity of the qu ...... olated at community hospitals.
@en
P2093
Goldstein EJ
P2860
P304
P356
10.1128/AAC.27.4.657
P407
P577
1985-04-01T00:00:00Z